
Velphoro
My Prescription
Payment
Select pharmacy




$1,556.30
Print or send this coupon to your phone
About Velphoro
Drug Details
Sucroferric oxyhydroxide is a medication used to reduce high phosphate levels in individuals undergoing dialysis due to advanced kidney disease. Dialysis alone may not effectively manage phosphate levels, and this medication aids in maintaining balance. By lowering phosphate levels, it helps maintain bone strength, prevents harmful mineral accumulation, and reduces the risk of heart disease and stroke associated with elevated phosphate levels. This drug contains a form of iron that is not absorbed by the body. Instead, it acts as a phosphate binder, attracting phosphates from the diet and facilitating their elimination through stool. Available in a convenient chewable tablet form, it is specifically designed for those with chronic kidney disease on dialysis, offering an essential tool in managing the complications associated with high phosphate levels.
Price history for Velphoro
90 Tablet Chewables, 500MG
Average retail price for Velphoro
Average SaveHealth price for Velphoro
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Velphoro dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 500MG | 90 Tablet Chewables | $1,556.50 | $17.29 |
Velphoro FAQs
Velphoro is used to control serum phosphorus levels in patients with chronic kidney disease on dialysis. It helps prevent the buildup of phosphorus in the blood, which can lead to bone and cardiovascular complications.
Velphoro and sevelamer are both medications used to manage hyperphosphatemia in patients with chronic kidney disease on dialysis, but they differ in composition and mechanism. Velphoro contains sucroferric oxyhydroxide, which binds dietary phosphate in the gastrointestinal tract, reducing phosphate absorption. Sevelamer, on the other hand, is a non-calcium, non-metal-based phosphate binder that also reduces phosphate absorption but is available in two forms: sevelamer carbonate and sevelamer hydrochloride. The choice between them may depend on patient-specific factors, including tolerance, side effects, and other medical conditions.
Yes, Velphoro is a phosphate binder. It is used to control serum phosphorus levels in patients with chronic kidney disease on dialysis.
Velphoro (sucroferric oxyhydroxide) is a phosphate binder used to control serum phosphorus levels in patients with chronic kidney disease on dialysis. It does not increase calcium levels; in fact, it is calcium-free, which makes it a suitable option for patients who need to manage phosphorus levels without affecting calcium levels.
A potential substitute for Velphoro, which is used to control serum phosphorus levels in patients with chronic kidney disease on dialysis, could be other phosphate binders. These alternatives may include sevelamer (Renvela or Renagel), lanthanum carbonate (Fosrenol), or calcium acetate (PhosLo). It is important for patients to consult with their healthcare provider to determine the most appropriate option based on their specific medical condition and needs.